Tag: Science
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
Understanding and Addressing Cardiovascular Health Disparities: Insights from Recent Studies
The recent election results may have shifted focus away from diversity, equity, and inclusion, but new research papers emphasize the importance of addressing health disparities based on socioeconomic factors. These papers, set to be...
Navigating Sickle Cell Pain, Loss, and Survival in America
Today, I want to talk about Tammy Clemons, a woman who is navigating the challenges of living with sickle cell disease in America. Tammy's story is one of pain, loss, and survival, and it...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
Seminal Moment for Science Journalism: A Letter from the Executive Editor
Dear Readers,I have written to you before to talk about the importance of subscribing to STAT for our comprehensive coverage of health and medicine. Today, I feel compelled to reiterate this message as we...
Biotech Outlook Post-Trump Presidency: What’s Next?
Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...
Uncovering the Link Between Cerebral Palsy and Vaccines
Cerebral palsy is a common motor disability that is often associated with childhood. However, there are actually more adults living with this condition in the United States than children. Transitioning from pediatric care to...
